Immunitybio Inc (IBRX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt IBRX? Forum Prognose

Finanzdaten der Immunitybio Inc-Aktie (IBRX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	71.22% 0.04	0.139	0.082	0.041	0.36
Operating Expenses	11.35% 95.24	85.53	80.22	85.19	111.94
Interest Income/Expense	8.23% 29.48	32.13	35.02	32.23	29.82
Benefits Costs and Expenses	42.56% 134.17	233.59	95.72	138.25	116.94
Costs And Expenses	42.56% 134.17	233.59	95.72	138.25	116.94
Operating Income/Loss	11.49% -95.20	-85.39	-80.14	-85.14	-111.58
Nonoperating Income/Loss	73.70% -38.93	-148.06	-15.51	-53.07	-5.003
Income/Loss From Equity Method Investments	-	-	-1.255	-3.957	-2.337
Income/Loss From Continuing Operations Before Tax	42.55% -134.13	-233.45	-95.64	-138.21	-116.58
Income Tax Expense/Benefit	100.00% -	-0.04	-	-	-
Income/Loss From Continuing Operations After Tax	42.54% -134.13	-233.41	-95.64	-138.21	-116.58
Net Income/Loss	42.54% -134.13	-233.41	-95.64	-138.21	-116.58
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	4.55% -0.021	-0.022	-0.06	-0.334	-0.24
Basic Average Shares	1,154% 672.83	53.64	498.38	437.46	428.38
Diluted Average Shares	1,154% 672.83	53.64	498.38	437.46	428.38
Basic Earnings Per Share	47.37% -0.20	-0.38	-0.19	-0.32	-0.27
Diluted Earnings Per Share	47.37% -0.20	-0.38	-0.19	-0.32	-0.27
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$18.98

3.66%

INCY

$76.97

1.45%

MRNA

$39.51

7.22%

UTHR

$359.21

1.11%

BGNE

$187.69

0.81%

BNTX

$101.87

2.16%